Placebo to AZD6765: Clinical Trials

1 trial of Placebo to AZD6765, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Placebo to AZD6765: new trials by email Literature Review of Placebo to AZD6765 trials Research Report on Placebo to AZD6765

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Study to Determine the Antidepressant Effects of AZD6765
AZD6765, Placebo to AZD6765 - Treatment Resistant Major Depressive Disorder
Phase 2CompletedAstraZeneca222009-12-012014-10-21

Sponsors

AstraZeneca (1)

Countries

United States (1)

Top investigators

Carlos A Zarate, MD (1)

Results publications

PMID 23206319, PMID 27914292, PMID 34510411